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The inositol ipid kinases were investigated in the cytoskeletons of human platelets. In the absence of added lipids the 
kinases were only barely detectable inthe Triton-soluble fractions and undetectable in cytoskeletons of resting cells. How- 
ever at least 30% of the total phosphatidylinositol kinase was present in the cytoskeleton as revealed by saturation of 
the enzyme. Phosphatidylinositol 4-phosphate kinase was also found in significant amounts in the cytoskeletons. On the 
other hand, both enzymes being only recovered in the particulate fraction of the cells, we suggest that inositol ipid kinases 
may be present near the anchoring points of the cytoskeletons atthe membranes. 
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1. INTRODUCTION 
The role of phosphatidylinositol 4,5-bisphos- 
phate (Ptdlns(4,5)P2) in platelet activation may be 
viewed from several aspects. Firstly, there have 
been numerous studies describing its hydrolysis by 
phospholipase C as one of the earliest events 
following the binding of a variety of agonists to 
their membrane receptors [1-7]. This contributes 
to an increase of intracytoplasmic Ca2÷ [8,9] and 
to activation of calmodulin-dependent protein 
kinase and protein kinase C [10]. Secondly, the 
relationship between Ptdlns(4,5)P2 metabolism 
and the dramatic morphological changes also oc- 
curring immediately after agonist binding begins to 
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be explored. Reorganization f cytoskeleton is ac- 
companied by a series of protein phosphorylations 
including those of myosin light chain and actin- 
binding protein [11-13] and so may be understood 
as a consequence of Ptdlns(4,5)P2 breakdown. On 
the other hand, Lassing and Lindberg [14] have 
shown that Ptdlns(4,5)P2 can bind to profilin, 
cause a rapid and efficient dissociation of profilac- 
tin and thus liberate G-actin for polymerisation. I  
this case, the generation of Ptdlns(4,5)P2 could 
control the first morphological changes following 
F-actin formation [15]. Sustaining this hypothesis, 
we have previously described an increase in the 
platelet content of phosphatidylinositol 4-phos- 
phate (Ptdlns(4)P) and Ptdlns(4,5)P2 upon throm- 
bin treatment [16,17]. 
Here, we report on further evidence for a possi- 
ble close relationship between polyphosphoinosi- 
tides and cytoskeletal proteins, since the present 
study demonstrates the association of phosphati- 
dylinositol kinase (Ptdlns kinase) and Ptdlns(4)P 
kinase with the cytoskeleton i human platelets. 
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2. EXPERIMENTAL 
2.1. Isolation of cytoskeleton 
Washed human platelets (2-3 x 109 ml -~) were suspended in
Tyrode's solution (pH 7.35) containing 2.5 mM Ca 2+, l mM 
Mg 2÷ and 0.35070 (w/v) bovine serum albumin [18]. Aliquots 
(0.5 ml) were triggered by thrombin (l IU.m1-1) for 1 rain at 
20°C in the presence (stimulated platelets) or absence (ag- 
gregated platelets) of 10 mM EGTA. Cytoskeletons were ob- 
tained by addition of 1 vol. of a lysis buffer containing 2070 
Triton X-100, 10 mM EGTA, 2 mM PMSF, 0.2 mM leupeptin 
and 50 mM Tris-HC1 (pH 7.4). After 5 min at room 
temperature followed by 10 min on ice, cytoskeletons were 
pelleted by centrifugation (4000 × g/20 min/4°C), as described 
elsewhere [19]. The pelleted cytoskeletons were further washed 
with lysis buffer diluted twice with 50 mM Tris-HCl, pH 7.4, 
and finally resuspended in 0.5 ml of 50 mM Tris-HCl, pH 7.4, 
by brief sonication (3 × 10 s, MSE sonifier, maximum output). 
Supernatants (0.1 ml) i.e. Triton-soluble material, were diluted 
with 4 vol. of 50 mM Tris-HCl (pH 7.4) when assayed for 
PtdIns and PtdIns(4)P kinase activities. Protein content was 
measured as in [20]. 
2.2. Assay of Ptdlns and PtdIns(4)P kinases 
The assay mixture (0.52 ml) was made of 80/zM [7-32P]ATP 
(10 Ci/mmol), 10 mM MgC12, 50 mM Tris-HCl (pH 7.4). 
When noted, sonicated Ptdlns and/or PtdIns(4)P were added at 
the concentrations indicated in the legends. After 5 rain at 37°C 
in a shaking water bath, the reaction was stopped by adding 
0.025 ml of 200 mM EDTA (pH 7.4) and lipids were im- 
mediately extracted [21,22]. Inositol lipids were separated by 
thin-layer chromatography [22]. After autoradiography (MP 
films, Amersham) radioactive spots were scraped off and 
counted in Instagel (Packard). 
2.3. Electrophoresis 
5 vols of washed cytoskeletons were dissolved in 1 vol. of 
6.6070 SDS, 0.6 M ~'-mercaptoethanol, 15 mM EDTA, 6007o 
glycerol and heated in boiling water for 2 rain. SDS- 
polyacrylamide gel electrophoresis was then carried out as in 
[23] using a 7.5-1207o acrylamide gradient for the resolving el. 
Gels were stained with Coomassie brilliant blue. 
2.4. Primary fractionation of platelets 
Platelet suspension i 50 mM Tris-HCl, pH 7.4 (0.5 ml), was 
sonicated on ice for 3 × 10 s (MSE sonifier, maximum output) 
and then centrifuged for 90 min, 105000 × g, at 4°C. Par- 
ticulate and cytosoluble fractions were then assayed for PtdIns 
and PtdIns(4)P kinases as described above (150-250/zg pro- 
teins per assay). 
2.5. Materials 
PtdIns, Ptdlns(4)P, PtdIns(4,5)P2 were from Sigma (St. 
Louis, MO); [y-32p]ATP was from Amersham plc (Amersham, 
England). 
3. RESULTS 
3.1. Association of  Ptdlns and Ptdlns(4)P kinases 
with the particulate fraction 
As previously described in other cells [24-26], 
we have noted an almost exclusive localisation of 
Ptdlns and Ptdlns(4)P kinases in the particulate 
fraction of platelets (table 1). Addition of 
exogenous Ptdlns revealed little Ptdlns and 
Ptdlns(4)P kinase activities in the cytosol and a 
non-significant enhancement of particulate ac- 
tivities. The same kind of effects were observed 
upon addition of Ptdlns(4)P in both cytosol and 
particulate fractions. In conclusion, it appeared 
that most if not all of the activities were associated 
with organelles. 
3.2. Association of  Ptdlns and Ptdlns(4)P kinases 
with the cytoskeleton 
When platelets were extracted with 1 °70 Triton 
X-100, we obtained a so-called cytoskeleton as 
shown in fig.1. Stimulation by thrombin 
(1 IU.m1-1) in the absence or presence of EGTA 
led to the appearance of aggregated or only 
stimulated platelets, respectively, allowing one to 
Table 1 
Inositol lipid kinases in cytosol and particulate fractions from platelets 
Ptdlns kinase Ptdlns4P kinase 
Addition None Ptdlns Ptdlns4P None Ptdlns Ptdlns4P 
Cytosol SA 0.7 + 0.3 3.5 _+ 1.6 0.8 + 0.2 0.1 _ 0.02 1.0 + 0.5 2.7 + 2.1 
070 2.6 + 1.1 11.8 ± 6.4 0.9 _+ 0.4 1.6 ± 0.2 9.8 ± 5.7 13.1 _+ 4.9 
Membranes SA 47.7 ± 7.0 63.1 ± 20.6 68.7 _+ 22.4 10.2 + 2.4 11.9 +_ 2.5 12.0 _+ 4.1 
070 97.4 _ 1.1 88.2 ± 6.4 99.1 ± 0.4 98.4 ± 0.2 90.2 ± 5.7 86.9 +_ 4.9 
Results are mean values + SE (n = 4) and are expressed as specific activities (SA): pmol of phosphorylated 
l ipid-min- ~. mg protein-t or as percentages of the total activities (°70) 
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Fig.2. Substrate dependency of Ptdlns kinase. Triton 
X-100-soluble and -insoluble fractions from stimulated platelets 
were incubated as indicated in section 2. Results are mean 
values _+ SE f rom 5 to 8 independent experiments for 
cytoskeleton (open circles) and f rom 4 experiments for the 
Triton-soluble supernatant (closed circles). Protein concentra- 
tions were 285 _+ 38/~g per assay for cytoskeleton and 185 +_ 
22/~g per assay for the Triton-soluble fraction. 
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Fig.l. Electrophoretic patterns of Triton insoluble material 
f rom platelets. SDS-po lyacry lamide  gel electrophoresis on 
7.5-1207o acrylamide of Triton-insoluble cytoskeletons 
prepared from thrombin-activated platelets (S) and thrombin- 
aggregated platelets (A). 
concentrations (not shown). It was verified that 
0.2o/0 Triton X-100 did not significantly modify 
the kinase activities in the cytoskeleton (95.0 + 
5.8O7o of control values, n = 4). 
Figs 2 and 3 depict the saturation curves of 
Ptdlns and PtdIns(4)P kinases obtained for both 
the cytoskeleton and Triton-soluble fraction of 
stimulated platelets. It was clear that addition of 
PtdIns and PtdIns(4)P to either preparation in- 
creased inositol lipid kinase activities. 
As seen in fig.2, the mean specific activity of 
PtdIns kinase was 120 _+ 37 pmol PtdIns(4)P pro- 
duced-min- l .mg protein-1 (n = 5) in the 
cytoskeleton and 53 + 15 pmol Ptdlns(4)P pro- 
obtain electrophoresis patterns similar to those 
previously described by others [19,27]. 
We could detect both PtdIns and PtdIns(4)P 
kinases in these cytoskeletons, in the presence of 
added inositol phospholipids (figs 2,3). Such an ac- 
tivity could also be found in the supernatants ob- 
tained after removal of Triton X-100-insoluble 
material (i.e. cytoskeletons) and diluted in order to 
obtain a final Triton X-100 concentration of 0.2°7o 
for PtdIns and PtdIns(4)P kinase assays. This dilu- 
tion also allowed us to adjust the protein concen- 
tration of Triton-soluble proteins to that obtained 
with cytoskeletons. Furthermore, it avoided inhibi- 
tion of kinase activities observed with high Triton 
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Fig.3. Substrate dependency of PtdIns(4)P kinase. For legend 
see f ig.2. 
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Table 2 
Comparison of the properties of cytoskeletons from stimulated 
and aggregated platelets 
Added lipids Stimulated Aggregated 
(~M) 
°7o of total 
proteins 15.4 + 0.2 16.5 ± 1.1 
Specific activities 0 0.6 ± 0.2 3.7 _+ 1.0 
160 120.0 _+ 37.0 93.5 ± 2.7 
Total amounts 0 0.2 _+ 0.1 1.4 ___ 0.4 
160 32.3 + 10.4 30.0 +_ 3.2 
Results are mean values _+ SE (n = 5) and are expressed as pmol 
of phosphorylated l ipids.mg protein- l .min-~ for specific 
activities and as pmol of phosphorylated lipids • min-  1 for total 
activity in cytoskeletons 
duced, min -1. mg protein-~ (n = 4) in the Triton- 
soluble fraction when phosphoinositides were ad- 
justed to 160/zM. Since 15.4 _+ 0.2°7o (n = 4) of the 
total proteins were recovered in the cytoskeleton of
stimulated platelets, at least 30°70 of Ptdlns kinase 
were associated with the cytoskeleton. On the 
other hand, due to the atypical behaviour of the 
Ptdlns(4)P kinase (fig.3), we could not obtain 
quantitative comparisons of activities in the two 
fractions. 
Spontaneous activities of both Ptdlns and 
Ptdlns(4)P kinases (i.e. without any substrate ad- 
dition) were only detectable in Triton-soluble frac- 
tions while cytoskeleton failed to incorporate 
significant amounts of 32p into lipids. However, 
the comparison of the data obtained in either 
stimulated or aggregated platelet cytoskeletons 
even in the presence of 160/zM PtdIns plus 
PtdIns(4)P did not reveal any significant variation 
in their total amounts of PtdIns kinase. 
4. DISCUSSION 
These data show an association of Ptdlns and 
Ptdlns(4)P kinases with the Triton-insoluble frac- 
tion of platelets, i.e. with the so-called 
cytoskeleton. A similar finding has been reported 
for Ptdlns kinase in erythrocytes [28]. On the other 
hand, we have confirmed the association of the 
kinases with the particulate fraction of platelets. It 
appears therefore that Ptdlns and Ptdlns(4)P 
kinases might be present at anchoring points of the 
cytoskeleton in the plasma membrane (and 
possibly other organelles). Such an association of 
the cytoskeleton with membrane enzymes has 
already been described even for intrinsic proteins 
such as glycoproteins l ib/ I l ia,  Ib or Ia [29-32]. 
We have also previously reported the association 
of some membrane lipids with the cytoskeleton 
[33] and more importantly, Verhallen et al. [34] 
have shown the role of intact cytoskeleton i  main- 
taining membrane asymmetry which is essential for 
platelet function. We report here a new type of in- 
teraction between cytoskeleton and lipids: since 
Ptdlns(4,5)P2 availability is a key process in the 
agonist-activated production of diglyceride and 
inositol 1,4,5-trisphosphate, i  appears that an im- 
portant part of the enzyme activities responsible 
for the stability of Ptdlns(4,5)P2 level is associated 
with cytoskeleton. This opens a new way for 
understanding the regulation of this process. Ac- 
tually, an interesting point is the possible regula- 
tion of Ptdlns kinase by tyrosine kinases [35-37] 
and it is interesting to note that two major tyrosine 
kinases, pp60 src, which is present in significant 
amounts in platelets [38,39], and epidermal growth 
factor receptor, have been described associated 
with cytoskeletal structures [40,41]. 
The existence of cytoskeletal interactions with 
phospholipids can also be viewed in the opposite 
way, the phospholipids regulating the status of the 
cytoskeleton. For instance, Ptdlns(4,5)Pz causes a 
rapid dissociation of profilactin which is accom- 
panied by polymerisation f G-actin [14]. We have 
shown that Ptdlns(4,5)P2 are not only degraded 
upon platelet stimulation but, after a rapid 
decrease, are synthesized in excess compared to the 
basal state [16,17]. Therefore, such an increase can 
be suggested as a means of regulating actin 
polymerization, an essential step in platelet ac- 
tivation. 
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